LAURUSLABS Laurus Labs Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareLive setups screens LAURUSLABS is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about LAURUSLABS
In the last completed session, Laurus Labs Ltd. closed +1.25% with futures open interest moving -0.3%. Positioning is neutral — neither side is decisively adding or unwinding right now. The option PCR of 0.99 is balanced — no clear directional preference from option writers. Max-pain strike at ₹1,760 sits 4.6% below the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Laurus Labs Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Laurus Labs Ltd. is best read as range-bound for now.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Insider & Promoter Filings last 60 days
Option Chain Ladder nearest expiry 2026-08-25 · spot 1,845 · EOD 2026-08-07
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 34%
Δ 0.85
θ -1.2
ν 1
|
1720 |
IV 32%
Δ -0.14
θ -0.8
ν 1
|
|
IV 33%
Δ 0.82
θ -1.3
ν 1
|
1740 |
IV 31%
Δ -0.17
θ -0.9
ν 1
|
|
IV 31%
Δ 0.78
θ -1.3
ν 1
|
1760 MP |
IV 30%
Δ -0.21
θ -0.9
ν 1
|
|
IV 29%
Δ 0.74
θ -1.3
ν 1
|
1780 |
IV 29%
Δ -0.26
θ -1.0
ν 1
|
|
IV 30%
Δ 0.68
θ -1.4
ν 1
|
1800 R |
IV 28%
Δ -0.31
θ -1.1
ν 1
|
|
IV 29%
Δ 0.62
θ -1.5
ν 2
|
1820 |
IV 28%
Δ -0.38
θ -1.1
ν 2
|
|
IV 28%
Δ 0.55
θ -1.5
ν 2
|
1840 |
IV 27%
Δ -0.45
θ -1.1
ν 2
|
|
IV 28%
Δ 0.48
θ -1.4
ν 2
|
1860 |
IV 27%
Δ -0.52
θ -1.1
ν 2
|
|
IV 27%
Δ 0.41
θ -1.4
ν 2
|
1880 |
IV 27%
Δ -0.60
θ -1.0
ν 2
|
|
IV 27%
Δ 0.34
θ -1.3
ν 1
|
1900 |
IV 27%
Δ -0.66
θ -0.9
ν 1
|
|
IV 27%
Δ 0.28
θ -1.2
ν 1
|
1920 |
IV 52%
Δ -0.61
θ -2.1
ν 2
|
|
IV 28%
Δ 0.22
θ -1.0
ν 1
|
1940 |
IV 43%
Δ -0.68
θ -1.5
ν 1
|
|
IV 28%
Δ 0.18
θ -0.9
ν 1
|
1960 |
IV 30%
Δ -0.81
θ -0.7
ν 1
|
Chain Interpretation
Strategy Builder multi-leg payoff for LAURUSLABS options · 2026-08-25 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
LAURUSLABS — frequently asked questions
What is the Laurus Labs Ltd. share price today?
LAURUSLABS is trading at ₹1,844.30 (+0.78% vs previous close), per the latest update on this page.
What is the P/E ratio of Laurus Labs Ltd.?
LAURUSLABS (Laurus Labs Ltd.) has a trailing twelve-month P/E ratio of 90.8.
What is the market cap of Laurus Labs Ltd.?
LAURUSLABS has a market capitalisation of approximately ₹99,650 crore.
Is LAURUSLABS near its 52-week high?
LAURUSLABS is trading -0.7% from its 52-week high of ₹1,856.60 as of 2026-08-07.
What is the RSI of LAURUSLABS?
The 14-day RSI of LAURUSLABS is 79.0, which is considered overbought.
Is LAURUSLABS above its 200-day moving average?
LAURUSLABS is trading above its 200-DMA of ₹1,184.01 (+55.8% away).
What is the F&O buildup in LAURUSLABS?
The latest end-of-day derivatives data classifies LAURUSLABS as Neutral (bias: neutral), based on the day's combined price and open-interest change.
What is the max pain and PCR for LAURUSLABS options?
LAURUSLABS's option-chain max pain strike is ₹1,760 and its put-call ratio (OI) is 0.99, from the latest end-of-day option chain.
Are FIIs or big investors buying LAURUSLABS?
Strota tracks every bulk and block deal in LAURUSLABS with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.